136 related articles for article (PubMed ID: 21415555)
41. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
42. C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus.
Sonoda R; Tanaka K; Kikuchi T; Onishi Y; Takao T; Tahara T; Yoshida Y; Suzawa N; Kawazu S; Iwamoto Y; Kushiyama A
PLoS One; 2016; 11(2):e0147303. PubMed ID: 26849676
[TBL] [Abstract][Full Text] [Related]
43. C-peptide immunoreactivity and insulin content in the diabetic human pancreas and the relation to the stability of diabetic serum glucose level.
Tasaka Y; Marumo K; Inoue Y; Hirata Y
Acta Endocrinol (Copenh); 1986 Nov; 113(3):355-62. PubMed ID: 3538738
[TBL] [Abstract][Full Text] [Related]
44. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264
[TBL] [Abstract][Full Text] [Related]
45. Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy.
Meier JJ; Pennartz C; Schenker N; Menge BA; Schmidt WE; Heise T; Kapitza C; Veldhuis JD
Diabetes Obes Metab; 2013 Mar; 15(3):258-63. PubMed ID: 23039360
[TBL] [Abstract][Full Text] [Related]
46. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
[TBL] [Abstract][Full Text] [Related]
47. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
48. Preoperative insulin secretion ability and pancreatic parenchymal thickness as useful parameters for predicting postoperative insulin secretion in patients undergoing pancreaticoduodenectomy.
Yoshikawa A; Kozawa J; Okita K; Yoneda S; Okauchi Y; Uno S; Iwahashi H; Ohira T; Takiuchi D; Eguchi H; Takeda Y; Imagawa A; Shimomura I
Endocr J; 2012; 59(5):383-92. PubMed ID: 22374239
[TBL] [Abstract][Full Text] [Related]
49. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.
Furuta M; Tamai M; Hanabusa T; Yamamoto Y; Nanjo K; Sanke T
Diabetes Res Clin Pract; 2006 Jun; 72(3):302-7. PubMed ID: 16442181
[TBL] [Abstract][Full Text] [Related]
50. C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes.
Iwamoto Y; Kimura T; Shimoda M; Morimoto Y; Watanabe Y; Itoh T; Sasaki T; Mori S; Kubo M; Takenouchi H; Dan K; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Nakanishi S; Mune T; Kaku K; Kaneto H
Diabetes Obes Metab; 2024 Jul; 26(7):2761-2773. PubMed ID: 38646845
[TBL] [Abstract][Full Text] [Related]
51. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
Deng Y; Zhang Y; Zheng S; Hong J; Wang C; Liu T; Sun Z; Gu W; Gu Y; Shi J; Yao S; Wang W; Ning G
J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350
[TBL] [Abstract][Full Text] [Related]
52. Short and Long Term Effects of a DPP-4 Inhibitor Versus Bedtime NPH Insulin as ADD-ON Therapy in Patients with Type 2 Diabetes.
da Silva GM; Nogueira KC; Fukui RT; Correia MR; Dos Santos RF; da Silva ME
Curr Pharm Des; 2016; 22(44):6716-6721. PubMed ID: 27928958
[TBL] [Abstract][Full Text] [Related]
53. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
[TBL] [Abstract][Full Text] [Related]
54. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
55. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function.
Alba M; Ahrén B; Inzucchi SE; Guan Y; Mallick M; Xu L; O'Neill EA; Williams-Herman DE; Kaufman KD; Goldstein BJ
Diabetes Obes Metab; 2013 Dec; 15(12):1101-10. PubMed ID: 23782502
[TBL] [Abstract][Full Text] [Related]
56. Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes.
Thompson RG; Gottlieb A; Organ K; Koda J; Kisicki J; Kolterman OG
Diabet Med; 1997 Jul; 14(7):547-55. PubMed ID: 9223392
[TBL] [Abstract][Full Text] [Related]
57. Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes.
Kozawa J; Okita K; Iwahashi H; Yamagata K; Imagawa A; Shimomura I
Endocr J; 2013; 60(6):813-8. PubMed ID: 23459463
[TBL] [Abstract][Full Text] [Related]
58. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
[TBL] [Abstract][Full Text] [Related]
59. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure.
Funakoshi S; Fujimoto S; Hamasaki A; Fujiwara H; Fujita Y; Ikeda K; Hamamoto Y; Hosokawa M; Seino Y; Inagaki N
Diabetes Res Clin Pract; 2008 Dec; 82(3):353-8. PubMed ID: 18950889
[TBL] [Abstract][Full Text] [Related]
60. C-peptide concentrations in patients with type 2 diabetes treated with insulin.
Uzunlulu M; Oguz A; Arslan Bahadir M; Erbakan AN; Vural Keskinler M; Alpaslan Mesci B
Diabetes Metab Syndr; 2019; 13(6):3099-3104. PubMed ID: 31785503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
